Overview
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
1 eventEthyol: FDA approved
To reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Primary hepatic neuroendocrine carcinoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Primary hepatic neuroendocrine carcinoma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesEthyol
Medimmune Oncology, Inc.
Travel Grants
No travel grants are currently matched to Primary hepatic neuroendocrine carcinoma.
Community
No community posts yet. Be the first to share your experience with Primary hepatic neuroendocrine carcinoma.
Start the conversation →Latest news about Primary hepatic neuroendocrine carcinoma
No recent news articles for Primary hepatic neuroendocrine carcinoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Primary hepatic neuroendocrine carcinoma
Which specialists treat Primary hepatic neuroendocrine carcinoma?
6 specialists and care centers treating Primary hepatic neuroendocrine carcinoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Primary hepatic neuroendocrine carcinoma?
1 patient support program are currently tracked on UniteRare for Primary hepatic neuroendocrine carcinoma. See the treatments and support programs sections for copay assistance, eligibility, and contact details.